For cytomix treatment, human recombinant TNFɑ (R&D Systems), IFNɣ (R&D systems), and IL-1β (PeproTech) were dissolved in organoid media (without EGF or Nicotinamide), and added to organoid wells overnight for 16 h, after which organoids were washed twice with Advanced DMEM/F12 and then replaced with organoid media.
